Regencell Bioscience HoldingRGC
13F holders, Q3 2024 (September 30)2holders −1
0new positions
1sold out
$5.54avg. 13F price*
At the end of Q3 2024, 2 institutions reported holding Regencell Bioscience Holding (RGC) in their 13F filings, down 1 from Q2 2024. 0 opened new positions and 1 sold out. The largest holders were UBS Group AG ($99K) and BlackRock, Inc. ($1K).
- Company
- Regencell Bioscience Holding
- CUSIP
- G7487R100
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $44 |
All 13F filers, Q2 2024 → Q3 2024: 17,564 shares bought and 13 shares sold, net +17,551 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| UBS Group AG | 0.00% | Add +5629.5% | 17,876 | $99K |
| BlackRock, Inc. | 0.00% | — | 238 | $1K |
"% of holder's portfolio" is RGC's weight in each manager's 13F, not the share of Regencell Bioscience Holding the manager owns.